X0306 4 2020-06-25 false 0001636422 Health Catalyst, Inc. HCAT 0001780980 Burton Daniel D. C/O HEALTH CATALYST, INC. 3165 MILLROCK DRIVE, #400 SALT LAKE CITY UT 84121 true true false false Chief Executive Officer Common Stock 2020-06-25 4 M false 104662.00 4.42 A 262162.00 D Common Stock 2020-06-25 4 M false 8924.00 6.24 A 271086.00 D Common Stock 2020-06-25 4 S false 8924.00 31.53 D 262162.00 D Common Stock 2020-06-25 4 S false 104662.00 30.98 D 157500.00 D Common Stock 2020-06-25 4 M false 2883.00 4.42 A 160383.00 D Common Stock 2020-06-25 4 S false 2883.00 31.53 D 157500.00 D Common Stock 2020-06-26 4 M false 24439.00 6.24 A 181939.00 D Common Stock 2020-06-26 4 S false 24439.00 30.25 D 157500.00 D Stock Option (Right to Buy) 6.24 2020-06-25 4 M false 8924.00 0.00 D 2018-05-13 2024-06-12 Common Stock 8924.00 67541.00 D Stock Option (Right to Buy) 4.42 2020-06-25 4 M false 107545.00 0.00 D 2017-07-01 2023-07-01 Common Stock 107545.00 0.00 D Stock Option (Right to Buy) 6.24 2020-06-26 4 M false 24439.00 0.00 D 2018-05-13 2024-06-12 Common Stock 24439.00 43102.00 D The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.42 to $31.72, inclusive. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.42 to $31.41, inclusive. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.00 to $30.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). 25% of the 76,465 shares underlying the options vested in an annual installment on May 13, 2015 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on May 13, 2018. 25% of the 200,000 shares underlying the options vested in an annual installment on July 1, 2014 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on July 1, 2017. /s/ Daniel Orenstein, as Attorney-in-Fact 2020-06-29